Dupilumab for atopic dermatitis in metastatic cancer.
Jessica McClatchyGayle RossPublished in: The Australasian journal of dermatology (2024)
We present a case of a 47-year-old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.